It’s me, Linnea :)

If you are looking for motivation & inspiration in Lung Cancer then allow me to introduce with you, one & only “Linnea Olson”!!

life and breath: outliving lung cancer

Last night I drank half a bottle of wine and ate half a pint of ice cream for dinner. Had you been here, I would have offered you the other half(s). My sugar and grapes meal was a celebration, as yesterday I learned that my scans are still stable.

This felt like a big deal because the previous scan of my lungs had been flagged for possible progression. That was three months ago and I didn’t get anxious until the day before yesterday, when that old familiar feeling of dread hit me like a ton of bricks.

Back in the day I might have bounced this anxiety off of my spouse, but I am now more than four years into traveling solo. Although I am one tough mother, (and have a t-shirt that says as much) some days just being strong doesn’t quite cut it. Fortunately I have learned how…

View original post 243 more words

Lung Cancer Advocacy in India – National Coordinator for ALK Positive International Group

To continue with our ongoing efforts for Lung Cancer patients in India, Vivek has took the role & responsibility of National Coordinator of India for ALK Positive group which is an international group of Non-Small Cell Lung Cancer (NSCLC) patients and caregivers afflicted with the Anaplastic Lymphoma Kinase (ALK) gene mutation/rearrangement.

It is great responsibility & lots of work to do for ALK positive Lung Cancer patients in India.

If you come to know about any Lung Cancer patient in India with ALK positive mutation, then either:

 

ALK national coordinator

As Speaker at Novartis – Lung Cancer and Clinical Research Advocacy

27540037_1464450533683322_8146644053817892897_n.jpg

Kusum & I got wonderful advocacy opportunity as got honour to be invited as speaker at Novartis.

It was amazing to be there and to represent Cancer Patients & their needs, with thousands of Scientists & Global senior Leadership at Novartis.

Great experience…..Hope our story & discussions would have encouraged the Researchers to do more research for Lung Cancer patients globally & bring more Clinical Trials to India.

#WorldCancerDay 4th Feb
#PatientsEmpowerment
#NeedMoreResearch
#LungCancer
#LCSM
#ALKPositive

Our Interview and Blog by Dr Upal, LUNGevity

In a boost for our ongoing work & fight for better access to latest medicines for Cancer patients especially Lung Cancer patients in India, we got an honor to meet & interviewed by Dr Upal, Director of Patient FoRCe at LUNGevity (world largest, successful & influential Lung Cancer non-profit organization, based in US). Dr Upal who became a friend, mentor & guide as soon as we met, who in his short trip to India, ensured a visit to our place to meet.

We are learning, determined & getting more confident with increasing support to see a day when no Cancer patient in India will die, due to non-access of a medicine that is available in any country of world.

Link of blog as written by Dr Upal for LUNGevity website, based on our interview as below:

https://www.lungevity.org/for-patients-caregivers/blogs/voices-from-the-community/new-year-new-inspiration-and-new-resolutions

Lungevity.PNG

Lung Cancer Consortium Asia

IMG-20171217-WA0008Much needed conference on Lung Cancer as “Lung Cancer Consortium Asia” has happened in Mumbai, India.

It was great honor for me to present as panelist while having the big responsibility to rightly represent Lung Cancer patients, caregivers in India along with global patient support gp of NSCLC ALK+ patients.

“Lung Cancer Consortium Asia” conference has also provided rare opportunity of open, direct, honest discussion between country’s best Oncologists, Radiologist & Lung Cancer Patients, NGOs..Great discussion, Great Learning for all

Kudos to the organizers especially to Dr. Kumar Prabhash (Prof. Dept of Medical Oncology, Head Thoracic oncology, Tata Memorial Hospital). Such a humble, caring Doctor – think, talk and work only for patients

#LungCancerAdvocacy #RiseToSurviveCancer

ACCI 2017 – A conference held for”Affordable Cancer Care in India”

 

IMG-20171126-WA0011Recently we got the opportunity to attend a Cancer related conference on an important topic “Affordable Cancer Care in India” which was attended Minister of State in the Ministry of Health and Family Welfare, Govt of India, Bureaucrats including Director General of Health, Policy makers, country’s top Oncologists and many Innovator & Generic pharmaceutical industries representatives.

It was good conference as all topics were critical for patients and their family especially when comes to financial impact with Cancer. We want to congratulate ‘BCPBF The Cancer foundations’ and organisers to gather so many key stakeholders together and putting such critical patients sensitive & related topic on table.

Though as we experienced before affordability, access is issue. If we do not have access to right & latest medicines in India, then all other things would become secondary. And I got the opportunity to raise this point that before affordability, access is issue….access to latest medicines & clinical research for better treatment & long survival for Cancer patients in India in urgent medical need.

All discussions by panelists & speakers were open and progressive. I hope policy makers would hear the recommendations from conference.

But yes, one thing I found lacking and it is common in India but wish to share is – Lack of ‘patients voice’ or ’empowered patient voice’ in such important conferences & discussions. We are talking and caring about patients, in that scenario as very common in western countries where patients have empowered voice, patients advocates should be part of each sessions like Doctors were.  This will also help to understand the issue better as you are hearing who are suffering and to raise demands more strongly infront of policy makers. Despite that we are happy that stakeholders are thinking & talking about such sensitive topic where with Cancer, patients & family usually lost all available resources & have to struggle to survive.

We will continue to raise patients voice ✌️